ArticleJCI insight2021

Targeting Gi/o protein-coupled receptor signaling blocks HER2-induced breast cancer development and enhances HER2-targeted therapy.

Cancan Lyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.